These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 4129866)

  • 1. Relationship between NADH and NADPH oxidation during drug metabolism.
    Sasame HA; Mitchell JR; Thorgeirsson S; Gillette JR
    Drug Metab Dispos; 1973; 1(1):150-5. PubMed ID: 4129866
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of cytochrome P-450 in N-hydroxylation of 2-acetylaminofluorene.
    Thorgeirsson SS; Jollow DJ; Sasame HA; Green I; Mitchell JR
    Mol Pharmacol; 1973 May; 9(3):398-404. PubMed ID: 4122821
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of oxygenated cytochrome P-450 and of cytochrome b5 in hepatic microsomal drug oxidations.
    Baron J; Hildebrandt AG; Peterson JA; Estabrook RW
    Drug Metab Dispos; 1973; 1(1):129-38. PubMed ID: 4149374
    [No Abstract]   [Full Text] [Related]  

  • 4. Sex-dependent differences in drug metabolism in the rat. 3. Temporal changes in type I binding and NADPH-cytochrome, P-450 reductase during sexual maturation.
    Cohen GM; Mannering GJ
    Drug Metab Dispos; 1974; 2(3):285-92. PubMed ID: 4153061
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunochemical study on the route of electron transfer from NADH and NADPH to cytochrome P-450 of liver microsomes.
    Noshiro M; Harada N; Omura T
    J Biochem; 1980 Nov; 88(5):1521-35. PubMed ID: 7462192
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of inhibition of drug metabolic reactions.
    Gillette J; Sasame H; Stripp B
    Drug Metab Dispos; 1973; 1(1):164-75. PubMed ID: 4149379
    [No Abstract]   [Full Text] [Related]  

  • 7. Formation and binding of carbanions by cytochrome P-450 of liver microsomes.
    Ullrich V; Schnabel KH
    Drug Metab Dispos; 1973; 1(1):176-83. PubMed ID: 4149380
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the molecular function of cytochrome P-450 during drug metabolism.
    Estabrook RW; Matsubara T; Mason JI; Werringloer J; Baron J
    Drug Metab Dispos; 1973; 1(1):98-110. PubMed ID: 4149428
    [No Abstract]   [Full Text] [Related]  

  • 9. Electron transport components of hepatic microsomes. Solubilization, resolution, and recombination to reconstitute aniline hydroxylase activity.
    Fujita T; Mannering GJ
    J Biol Chem; 1973 Dec; 248(23):8150-6. PubMed ID: 4148101
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytochrome P-450 and its role in drug metabolism.
    Gillette JR; Davis DC; Sasame HA
    Annu Rev Pharmacol; 1972; 12():57-84. PubMed ID: 4114185
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic cytochrome P-450.
    Paine AJ
    Essays Biochem; 1981; 17():85-126. PubMed ID: 6795037
    [No Abstract]   [Full Text] [Related]  

  • 12. [P-450 cytochrome. Detoxication by liver microsomes].
    Gajdos A
    Nouv Presse Med; 1972 Jun; 1(23):1587-92. PubMed ID: 4402521
    [No Abstract]   [Full Text] [Related]  

  • 13. Liver microsomal drug-metabolizing enzyme system: functional components and their properties.
    Lu AY
    Fed Proc; 1976 Nov; 35(13):2460-3. PubMed ID: 824157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence against participation of cytochrome b5 in the hepatic microsomal mixed-function oxidase reaction.
    Jansson I; Schenkman JB
    Mol Pharmacol; 1973 Nov; 9(6):840-5. PubMed ID: 4148656
    [No Abstract]   [Full Text] [Related]  

  • 15. The possible involvement of cytochrome b5 in the oxidation of lauric acid by microsomes from kidney cortex and liver of rats.
    Sasame HA; Thorgeirsson SS; Mitchell JR; Gillette JR
    Life Sci; 1974 Jan; 14(1):35-46. PubMed ID: 4129689
    [No Abstract]   [Full Text] [Related]  

  • 16. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
    Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
    Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of cytochrome P-450 induction on the metabolic formation of 455-NM complexes from amphetamines.
    Franklin MR
    Drug Metab Dispos; 1974; 2(3):321-6. PubMed ID: 4153124
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunochemical evidence for the participation of cytochrome b5 in the NADH synergism of the NADPH-dependent mono-oxidase system of hepatic microsomes.
    Mannering GJ; Kuwahara S; Omura T
    Biochem Biophys Res Commun; 1974 Mar; 57(2):476-81. PubMed ID: 4151403
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced diphosphopyridine nucleotide synergism of the reduced triphosphopyridine nucleotide-dependent mixed-function oxidase system of hepatic microsomes. II. Role of the type I drug-binding site of cytochrome P-450.
    Correia MA; Mannering GJ
    Mol Pharmacol; 1973 Jul; 9(4):470-85. PubMed ID: 4146890
    [No Abstract]   [Full Text] [Related]  

  • 20. The involvement of NADH-cytochrome b5 reductase and cytochrome b5 complex in microsomal NADH-cytochrome c reductase activity. Changes in NADH-cytochrome c reductase activity following phenobarbital treatment.
    Starón K; Kaniuga Z
    Acta Biochim Pol; 1974; 21(1):61-6. PubMed ID: 4364831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.